Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
Publication
, Journal Article
Ogdie, A; de Wit, M; Callis Duffin, K; Campbell, W; Chau, J; Coates, LC; Eder, L; Elmamoun, M; FitzGerald, O; Gladman, DD; Goel, N; James, J ...
Published in: J Rheumatol
May 2017
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting in July 2016, the PsA working group presented the updated PsA core domain set endorsed by 90% of participants at OMERACT in May 2016 and drafted a roadmap for the development of the PsA core outcome measurement set. In this manuscript, we review the development process of the PsA core domain set and the ongoing and proposed work streams for development of a PsA core measurement set.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Rheumatol
DOI
EISSN
1499-2752
Publication Date
May 2017
Volume
44
Issue
5
Start / End Page
697 / 700
Location
Canada
Related Subject Headings
- Treatment Outcome
- Rheumatology
- Outcome Assessment, Health Care
- Humans
- Arthritis, Psoriatic
- Arthritis & Rheumatology
- Antirheumatic Agents
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Ogdie, A., de Wit, M., Callis Duffin, K., Campbell, W., Chau, J., Coates, L. C., … Orbai, A.-M. (2017). Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. J Rheumatol, 44(5), 697–700. https://doi.org/10.3899/jrheum.170150
Ogdie, Alexis, Maarten de Wit, Kristina Callis Duffin, Willemina Campbell, Jeffrey Chau, Laura C. Coates, Lihi Eder, et al. “Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.” J Rheumatol 44, no. 5 (May 2017): 697–700. https://doi.org/10.3899/jrheum.170150.
Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, et al. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. J Rheumatol. 2017 May;44(5):697–700.
Ogdie, Alexis, et al. “Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.” J Rheumatol, vol. 44, no. 5, May 2017, pp. 697–700. Pubmed, doi:10.3899/jrheum.170150.
Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, James J, Kalyoncu U, Latella J, Lindsay C, Mease PJ, O’Sullivan D, Steinkoenig I, Strand V, Tillett W, Orbai A-M. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. J Rheumatol. 2017 May;44(5):697–700.
Published In
J Rheumatol
DOI
EISSN
1499-2752
Publication Date
May 2017
Volume
44
Issue
5
Start / End Page
697 / 700
Location
Canada
Related Subject Headings
- Treatment Outcome
- Rheumatology
- Outcome Assessment, Health Care
- Humans
- Arthritis, Psoriatic
- Arthritis & Rheumatology
- Antirheumatic Agents
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services